Mitchell Glass
Director/Board Member at MYMD PHARMACEUTICALS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christopher Chapman | M | 71 | 4 years | |
| Christopher Schreiber | M | 58 | 7 years | |
| Joshua Silverman | M | 53 | 6 years | |
| Thian Chew | M | - |
Chronic Airway Therapeutics
 Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | 7 years |
| G. John Mohr | M | - |
Accolade Pharma LLC
 Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Accolade Pharma LLC is a pharmaceutical company that specializes in developing topical formulations and devices for the active ingredient of Accolate® (zafirlukast) to treat allergic inflammation. The private company is based in Wilmington, DE. Leukotriene antagonists modify allergic responses by blocking leukotrienes, which prevents or decreases symptoms of acute inflammation such as wheezing, sneezing, itching, redness, and swelling. The company was founded in 2012 by G. John Mohr, who has been the CEO since 2012. | 12 years |
| Michael DiPiano | M | 65 |
University City Science Center
 University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | 19 years |
| Bill White | M | 63 | 7 years | |
| Craig Eagle | M | 57 | 3 years | |
| Craig R. Carnaroli | M | - |
University City Science Center
University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | 19 years |
| Jude Uzonwanne | M | 50 | 3 years | |
| Michael P. Silvon | M | 76 |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | - |
| Ian Rhodes | M | 51 | 3 years | |
| Alan Yamashita | M | 74 | 5 years | |
| Vinod Vijayakumar | M | - |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Chronic Airway Therapeutics develops treatments for chronic respiratory diseases. The private company is based in Kew East, Australia. The CEO of the Australian company is Mitchell Glass. | - |
| Robert Schatz | M | - | - | |
| Jenna Brager | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregory Collier | M | - | 6 years | |
| Charles Deignan | M | 59 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 10 years |
| Craig Newton | M | - | 2 years | |
| Todd Eugene Petzel | M | - |
The University of Chicago
| 7 years |
| James Brett Lochran Heading | M | 67 | 4 years | |
| Sanford J. Grossman | M | - |
The University of Chicago
| 6 years |
| Geri Sands Hansen | F | - |
The University of Chicago
| 4 years |
| Don N. Kleinmuntz | M | - |
The University of Chicago
| 8 years |
| Mauricio Antonio González Gómez | M | - |
The University of Chicago
| 3 years |
| Sun Chi Chan | M | 73 |
The University of Chicago
| 4 years |
| Marc R. Reinganum | M | - |
The University of Chicago
| 5 years |
| Kenneth L. Cutler | M | - |
The University of Chicago
| 4 years |
| Mary Patricia Quinn | F | - |
The University of Chicago
| 5 years |
| Brady Dougan | M | 64 |
The University of Chicago
| 5 years |
| Ralph Craven | M | 73 | 4 years | |
| Richard Walter Grayston | M | 80 |
The University of Chicago
| 4 years |
| Cláudio Luiz da Silva Haddad | M | 77 |
The University of Chicago
| 4 years |
| Warren Thomas Brown | M | - | 7 years | |
| Mark P. Colonnese | M | 68 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 10 years |
| Theo Vermaelen | M | 70 |
The University of Chicago
| 6 years |
| Stu J. Sweet | M | - |
The University of Chicago
| 6 years |
| Manuel Iglesias | M | 69 |
The University of Chicago
| 6 years |
| Garner William | M | 58 | 1 years | |
| Bhanusak Asvaintra | M | 79 |
The University of Chicago
| 2 years |
| Victor Canto | M | - |
The University of Chicago
| 5 years |
| George K. Hersh | M | - |
The University of Chicago
| 6 years |
| Myron Samuel Scholes | M | 82 |
The University of Chicago
| 12 years |
| Michael Anthony Duffy | M | - |
The University of Chicago
| 8 years |
| Charles Frederick Pohl | M | - |
The University of Chicago
| 5 years |
| T. Eric Kilcollin | M | - |
The University of Chicago
| 5 years |
| Michael C. Markovitz | M | 70 |
The University of Chicago
| 3 years |
| Easton Ragsdale | M | 73 |
The University of Chicago
| 8 years |
| Robert Scott | M | 70 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | 6 years |
| Jeffrey Skelton | M | 74 |
The University of Chicago
| 6 years |
| George Masek | M | - |
The University of Chicago
| 2 years |
| Ronald Horne | M | 79 |
The University of Chicago
| 4 years |
| Seth Johnson | M | 70 |
The University of Chicago
| 2 years |
| Marcel Fournier | M | 69 |
The University of Chicago
| 2 years |
| Herbert W. Krueger | M | - |
The University of Chicago
| 3 years |
| Jay Cohen | M | - |
The University of Chicago
| 3 years |
| Joe Jesson | M | - |
The University of Chicago
| 4 years |
| David Cotton | M | 71 |
The University of Chicago
| 4 years |
| George N. Rifkin | M | - |
The University of Chicago
| 2 years |
| Gordon Hamilton | M | 68 |
The University of Chicago
| 4 years |
| Greg W. Renz | M | - |
The University of Chicago
| 3 years |
| Joe Rizzi | M | - |
The University of Chicago
| 2 years |
| John Osth | M | 77 |
The University of Chicago
| 2 years |
| John A. Salvette | M | 67 |
The University of Chicago
| 2 years |
| David Eisenbud | M | - |
The University of Chicago
| 3 years |
| Robert Dewing | M | - |
The University of Chicago
| 2 years |
| Gary I. Singer | M | - |
The University of Chicago
| 2 years |
| David L. Cotton | M | - |
The University of Chicago
| 1 years |
| Thomas H. Hopkins | M | - |
The University of Chicago
| 4 years |
| Brian Cartwright | M | 76 |
The University of Chicago
| 3 years |
| Randolph Richards | M | 69 |
The University of Chicago
| 2 years |
| John Baily | M | 80 |
The University of Chicago
| 2 years |
| John F. Rosenthal | M | - |
The University of Chicago
| 3 years |
| Adam de Sola Pool | M | - |
The University of Chicago
| 4 years |
| Joan Marie Giardina | F | 75 |
The University of Chicago
| 2 years |
| Merilee Raines | F | 68 |
The University of Chicago
| 2 years |
| Mitsuo Kitagawa | M | 77 |
The University of Chicago
| 1 years |
| James W. Lewis | M | 82 |
The University of Chicago
| 2 years |
| Tin Fan Yuen | M | 70 |
The University of Chicago
| 4 years |
| Thomas Tedoff Kutzen | M | 71 |
The University of Chicago
| 2 years |
| Robert F. Weber | M | - |
The University of Chicago
| 3 years |
| Lawrence Henry Neibor | M | 70 |
The University of Chicago
| 2 years |
| Craig R. Dean | M | - |
The University of Chicago
| 4 years |
| Stephen L. Schlader | M | - |
The University of Chicago
| 4 years |
| Gregory S. Samorajski | M | - |
The University of Chicago
| 2 years |
| Nicholas Pritzker | M | 79 |
The University of Chicago
| 3 years |
| Carlos Geraldo Langoni | M | 79 |
The University of Chicago
| 3 years |
| Robert j. Minkus | M | - |
The University of Chicago
| 3 years |
| Jay Trees | M | - |
The University of Chicago
| 2 years |
| Frank B. Chauner | M | - |
The University of Chicago
| 2 years |
| David J. Steirman | M | - |
The University of Chicago
| 2 years |
| Thomas A. Cole | M | - |
The University of Chicago
| 4 years |
| Stephen Timothy Kochis | M | - |
The University of Chicago
| 2 years |
| John Prann | M | 73 |
The University of Chicago
| 2 years |
| Steve Herman | M | 80 |
The University of Chicago
| 2 years |
| Philip Arthur Epstein | M | 67 |
The University of Chicago
| 4 years |
| Dominic C. Yang | M | - |
The University of Chicago
| 4 years |
| Daniel Zaldivar | M | - |
The University of Chicago
| 4 years |
| Tibor D. Klopfer | M | - |
The University of Chicago
| 3 years |
| Lawrence Kinet | M | 77 |
The University of Chicago
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 90 | 90.00% |
| Australia | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mitchell Glass
- Personal Network
